- Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira)John B Buse
University of North Carolina School of Medicine, Endocrinology and Metabolism, Chapel Hill, NC
Diabetes Care 37:2926-33. 2014..This trial investigated the contribution of the liraglutide component of IDegLira versus IDeg alone on efficacy and safety in patients with type 2 diabetes...
- Combining insulin and oral agentsJ Buse
University of North Carolina, School of Medicine, Chapel Hill, North Carolina 27713, USA
Am J Med 108:23S-32S. 2000..To date, however, clinical trial data are insufficient for use in determining the optimal combination of agents, insulin formulations, and dosages among the many currently available possibilities...
- Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programmeK Niswender
Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232 0475, USA
Diabetes Obes Metab 15:42-54. 2013..We investigated the relationship between weight change and related factors in subjects with type 2 diabetes mellitus (T2DM) treated with liraglutide versus comparator diabetes therapies...